Suppr超能文献

越南药品价格虚高:一项定性研究。

Inflated medicine prices in Vietnam: a qualitative study.

作者信息

Nguyen Tuan Anh, Knight Rosemary, Mant Andrea, Razee Husna, Brooks Geoffrey, Dang Thu Ha, Roughead Elizabeth Ellen

机构信息

Quality Use of Medicines and Pharmacy Research Centre, Sansom Institute, School of Pharmacy and Medical Sciences, University of South Australia, SA 5000, Australia.

School of Public Health and Community Medicine, University of New South Wales, NSW 2052, Australia.

出版信息

Health Policy Plan. 2017 Jun 1;32(5):647-656. doi: 10.1093/heapol/czw174.

Abstract

One third of the world's population lacks regular access to essential medicines partly because of the high cost of medicines. In Vietnam, the cost to patients of medicines was 47 times the international reference price for originator brands and 11 times the price for generic equivalents in the public sector. In this article, we report the results of a qualitative study conducted to identify the principal reasons for inflated medicine prices in Vietnam.Between April 2008 and December 2009, 29 semi-structured interviews were conducted with staff from pharmaceutical companies, private pharmacies, the Ministry of Health, and the Ministry of Finance of Vietnam. Study participants were recruited using a combination of purposive and snowball sampling techniques. Interviews were recorded, transcribed and coded using NVivo8® software and analyzed using a framework of structure-conduct-performance (SCP).Participants attributed high prices of originator medicines to a monopoly of supply. The prices of generic medicines were also considered to be excessive, reportedly due to the need to recoup the cost of financial inducements paid to prescribers and procurement officers. These inducements constituted a dominant cost component of the end price of generic medicines. Poor market intelligence about current world prices, as well as failure to achieve economies of scale because of unwarranted duplication in pharmaceutical production and distribution system were also factors contributing to high prices. This was reported to be further compounded by multiple layers in the supply chain and unregulated retail mark-ups.To address these problems a multifaceted approach is needed encompassing policy and legislative responses. Policy options include establishing effective monitoring of medicine quality assurance, procurement, distribution and use. Rationalization of the domestic pharmaceutical production and distribution system to achieve economies of scale is also required. Appropriate legal responses include collaborations with the justice and law enforcement sectors to enforce existing laws.

摘要

世界三分之一的人口无法定期获得基本药物,部分原因是药品成本高昂。在越南,患者购买药品的费用是原研品牌国际参考价格的47倍,是公共部门通用等效药品价格的11倍。在本文中,我们报告了一项定性研究的结果,该研究旨在确定越南药品价格虚高的主要原因。

2008年4月至2009年12月期间,对越南制药公司、私人药店、卫生部和财政部的工作人员进行了29次半结构化访谈。研究参与者采用目的抽样和滚雪球抽样技术相结合的方式招募。访谈进行了录音、转录,并使用NVivo8®软件进行编码,然后采用结构-行为-绩效(SCP)框架进行分析。

参与者将原研药品价格高归因于供应垄断。据报道,通用药品价格也过高,原因是需要收回支付给开处方者和采购官员的经济诱因成本。这些诱因构成了通用药品最终价格的主要成本组成部分。对当前世界价格的市场情报了解不足,以及由于制药生产和分销系统中不必要的重复而未能实现规模经济,也是导致价格高昂的因素。据报道,供应链中的多层环节和不受监管的零售加价进一步加剧了这一情况。

为解决这些问题,需要采取多方面的方法,包括政策和立法应对措施。政策选择包括对药品质量保证、采购、分销和使用建立有效的监测。还需要对国内制药生产和分销系统进行合理化,以实现规模经济。适当的法律应对措施包括与司法和执法部门合作,以执行现有法律。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验